Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, w ith low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C). 1 * 100 mg
Catalog # MDEXHY-12866
Supplier: MEDCHEMEXPRESS
Frequently Bought Together